Article ; Online: Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.
British journal of clinical pharmacology
2013 Volume 76, Issue 6, Page(s) 858–867
Abstract: ... pharmacodynamic interactions were observed with coadministered CQ and TQ in healthy subjects. ... interaction and for pharmacodynamic, safety and tolerability characteristics.: Methods: Healthy subjects ... Aims: The long-acting 8-aminoquinoline tafenoquine (TQ) coadministered with chloroquine (CQ ...
Abstract | Aims: The long-acting 8-aminoquinoline tafenoquine (TQ) coadministered with chloroquine (CQ) may radically cure Plasmodium vivax malaria. Coadministration therapy was evaluated for a pharmacokinetic interaction and for pharmacodynamic, safety and tolerability characteristics. Methods: Healthy subjects, 18-55 years old, without documented glucose-6-phosphate dehydrogenase deficiency, received CQ alone (days 1-2, 600 mg; and day 3, 300 mg), TQ alone (days 2 and 3, 450 mg) or coadministration therapy (day 1, CQ 600 mg; day 2, CQ 600 mg + TQ 450 mg; and day 3, CQ 300 mg + TQ 450 mg) in a randomized, double-blind, parallel-group study. Blood samples for pharmacokinetic and pharmacodynamic analyses and safety data, including electrocardiograms, were collected for 56 days. Results: The coadministration of CQ + TQ had no effect on TQ AUC0-t , AUC0-∞ , Tmax or t1/2 . The 90% confidence intervals of CQ + TQ vs. TQ for AUC0-t , AUC0-∞ and t1/2 indicated no drug interaction. On day 2 of CQ + TQ coadministration, TQ Cmax and AUC0-24 increased by 38% (90% confidence interval 1.27, 1.64) and 24% (90% confidence interval 1.04, 1.46), respectively. The pharmacokinetics of CQ and its primary metabolite desethylchloroquine were not affected by TQ. Coadministration had no clinically significant effect on QT intervals and was well tolerated. Conclusions: No clinically significant safety or pharmacokinetic/pharmacodynamic interactions were observed with coadministered CQ and TQ in healthy subjects. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | Administration, Oral ; Adolescent ; Adult ; Aminoquinolines/administration & dosage ; Aminoquinolines/adverse effects ; Aminoquinolines/pharmacokinetics ; Antimalarials/administration & dosage ; Antimalarials/adverse effects ; Antimalarials/pharmacokinetics ; Area Under Curve ; Chloroquine/administration & dosage ; Chloroquine/adverse effects ; Chloroquine/pharmacokinetics ; Double-Blind Method ; Drug Interactions ; Drug Therapy, Combination ; Female ; Glucosephosphate Dehydrogenase/genetics ; Glucosephosphate Dehydrogenase/metabolism ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Young Adult | |||||
Chemical Substances | Aminoquinolines ; Antimalarials ; tafenoquine (262P8GS9L9) ; Chloroquine (886U3H6UFF) ; Glucosephosphate Dehydrogenase (EC 1.1.1.49) | |||||
Language | English | |||||
Publishing date | 2013-05-23 | |||||
Publishing country | England | |||||
Document type | Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't | |||||
ZDB-ID | 188974-6 | |||||
ISSN | 1365-2125 ; 0306-5251 ; 0264-3774 | |||||
ISSN (online) | 1365-2125 | |||||
ISSN | 0306-5251 ; 0264-3774 | |||||
DOI | 10.1111/bcp.12160 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1118: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.